AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
280 hedge funds and large institutions have $2.32B invested in Amedisys in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 106 increasing their positions, 96 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.89% more ownership
Funds ownership: 95.71% → 96.6% (+0.89%)
10% less capital invested
Capital invested by funds: $2.56B → $2.32B (-$249M)
Holders
280
Holding in Top 10
2
Calls
$6.04M
Puts
$1.65M
Top Buyers
| 1 | +$25.5M | |
| 2 | +$20.8M | |
| 3 | +$17.5M | |
| 4 |
JP Morgan Chase
New York
|
+$17.4M |
| 5 |
EP
Eversept Partners
New York
|
+$16.5M |
Top Sellers
| 1 | -$78.7M | |
| 2 | -$46.1M | |
| 3 | -$19.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$15M |
| 5 |
Bank of New York Mellon
New York
|
-$9.81M |